MyBiotics Pharma Receives Investment from Mii Fund, an Innovator in the Field of Dermatology

 In news

03 Feb, 2021 – MyBiotics Pharma announced today that it has received an investment from Mii Fund, a partnership with Maruho Co. Ltd., Japan’s preeminent leader in dermatology.

MyBiotics will use the funds to advance its microbiome therapeutics pipeline and continue to enhance its unique microbiome platform technologies. In addition, the company is initiating a development program in the field of skin microbiome, leveraging the support of the Mii Fund & Lab, and the relationship with Maruho Co. Ltd, a leading market player in the dermatology market.